Delivery Order SPE2DB22D3301-SPE2DB24FY3HP
Award Date 3/26/24
Potential Completion Date 3/27/24
Potential Value $5.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of 4,563,492,997 units of Doxorubicin Liposome 50mg/25ml, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,500.00 firm-fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 30, 2024 with a completion date of January 31, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
- This federal contract award is for the delivery of Doxorubicin Liposome 50mg/25ml, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,500.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on February 9, 2024, with a completion date of February 12, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal healthcare programs,...
- This is a $3,404.64 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 50mg/25ml vials of the drug doxorubicin liposome, a chemotherapy medication. The award has a completion date of July 7, 2025 and is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award is a delivery order (SPE2DB20D3103|SPE2DB24FM4V2) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4563493004 - Doxorubicin Liposome 50mg/25ml 25ml. The $1,500.00 firm fixed price award was made by the Defense Logistics Agency (DLA) on January 30, 2024, with a completion date of January 31, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Doxorubicin Liposome 20mg/10ml pharmaceutical product, valued at $1,183.64 with a firm fixed price structure. The award, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the performing location for this delivery order, which falls under the...
- This federal contract award is for the delivery of 4559936723 - Doxorubicin Liposome 50mg/25ml, 25ml. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 14, 2023. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,467.98 and a completion date of February 15, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Doxorubicin Liposome 20mg/10ml in 10ml vials, with a contract ceiling value of $1,922.10 and an ultimate completion date of November 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract worth $1,726.81 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 50 mg Doxorubicin vials. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,399.76 firm fixed-price delivery order covers the supply of the specialty drug DOXIL 20 MG/10 ML VIAL 10ML, with a period of performance through December 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,633.80 firm fixed-price delivery order is for the supply of Doxil 50 mg/25 ml vials, with a completion date of December 30, 2021. The contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to the U.S. Department of...